Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current: A Possible Therapeutic Approach
Open Access
- 11 June 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 614
- https://doi.org/10.3389/fphar.2020.00614
Abstract
The incidence and mortality of cardiovascular disease in diabetic patients are 2-3 times higher than those in non-diabetic patients. Abnormal function of the L-type calcium channel in myocardial tissue might result in multiple cardiac disorders such as a prolonged QT interval. Therefore, QT prolongation is an independent risk factor of cardiovascular disease in patients with diabetes mellitus. Metformin, a hypoglycemic agent, is widely known to effectively reduce the occurrence of macrovascular diseases. The aim of the present study was to evaluate the effect of metformin on prolonged QT interval and to explore potential ionic mechanisms induced by diabetes. Diabetic mouse models were established with streptozotocin and an electrocardiogram was used to monitor the QT interval after 4 weeks of metformin treatment in each group. Action potential duration (APD) and L-type calcium current (ICa-L) were detected by patch-clamp in isolated mice ventricular cardiomyocytes and neonatal cardiomyocytes of mice. The expression levels ofCACNA1CmRNA and Cav1.2 were measured by real-time PCR, western blot and immunofluorescence. A shortened QT interval was observed after 4 weeks of metformin treatment in diabetic mice. Patch-clamp results revealed that both APD andI(Ca-L)were shortened in mouse cardiomyocytes. Furthermore, the expression levels ofCACNA1CmRNA and Cav1.2 were decreased in the metformin group. The same results were also obtained in cultured neonatal mice cardiomyocytes. Overall, these results verify that metformin could shorten a prolonged QT interval by inhibiting the calcium current, suggesting that metformin may play a role in the electrophysiology underlying diabetic cardiopathy.Funding Information
- National Natural Science Foundation of China (81674326, 81730012)
This publication has 48 references indexed in Scilit:
- Increased Persistent Sodium Current Due to Decreased PI3K Signaling Contributes to QT Prolongation in the Diabetic HeartDiabetes, 2013
- Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytesEuropean Heart Journal, 2013
- Metformin: an old but still the best treatment for type 2 diabetesDiabetology & Metabolic Syndrome, 2013
- Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic SubjectsDiabetes Care, 2012
- L-type Calcium Current (ICa,L) and Inward Rectifier Potassium Current (IK1) are Involved in QT Prolongation Induced by Arsenic Trioxide in RatCellular Physiology and Biochemistry, 2010
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesYearbook of Endocrinology, 2009
- Os efeitos da metformina sobre a dispersão do intervalo QT e QTc de ratos diabéticosArquivos Brasileiros de Cardiologia, 2008
- Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 GeneCirculation, 2007
- Action Potential Duration and QT Interval During Pinacidil Infusion in Isolated Rabbit HeartsJournal of Cardiovascular Electrophysiology, 2005
- Drug-Induced Prolongation of the QT IntervalThe New England Journal of Medicine, 2004